MAPK15 mediates BCR-ABL1-induced autophagy and regulates oncogene-dependent cell proliferation and tumor formation

References

• Rudkin CT, Hungerford DA, Nowell PC. DNA contents of chromosome Ph1 and chromosome 21 in human chronic granulocytic leukemia. Science 1964; 144:1229-31; PMID:14150328; http://dx.doi.org/10.1126/science.144.3623.1229
   PubMed Web of Science ®Google Scholar
• Rowley JD. Letter: A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining. Nature 1973; 243:290-3; PMID:4126434; http://dx.doi.org/10.1038/243290a0
   PubMed Web of Science ®Google Scholar
• Shtivelman E, Lifshitz B, Gale RP, Canaani E. Fused transcript of abl and bcr genes in chronic myelogenous leukaemia. Nature 1985; 315:550-4; PMID:2989692; http://dx.doi.org/10.1038/315550a0
   PubMed Web of Science ®Google Scholar
• Druker BJ, Tamura S, Buchdunger E, Ohno S, Segal GM, Fanning S, Zimmermann J, Lydon NB. Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr–Abl positive cells. Nature Med 1996; 2:561-6; PMID:8616716; http://dx.doi.org/10.1038/nm0596-561
   PubMed Web of Science ®Google Scholar
• Daley GQ, Baltimore D. Transformation of an interleukin 3-dependent hematopoietic cell line by the chronic myelogenous leukemia-specific P210bcr/abl protein. Proc Natl Acad Sci U S A 1988; 85:9312-6; PMID:3143116; http://dx.doi.org/10.1073/pnas.85.23.9312
   PubMed Web of Science ®Google Scholar
• Deininger MW, Goldman JM, Melo JV. The molecular biology of chronic myeloid leukemia. Blood 2000; 96:3343-56; PMID:11071626
   PubMed Web of Science ®Google Scholar
• Helgason GV, Karvela M, Holyoake TL. Kill one bird with two stones: potential efficacy of BCR-ABL and autophagy inhibition in CML. Blood 2011; 118:2035-43; PMID:21693757; http://dx.doi.org/10.1182/blood-2011-01-330621
   PubMed Web of Science ®Google Scholar
• Savona MR, Saglio G. Identifying the time to change BCR-ABL inhibitor therapy in patients with chronic myeloid leukemia. Acta Haematol 2013; 130:268-78; PMID:23949495; http://dx.doi.org/10.1159/000353163
   PubMed Web of Science ®Google Scholar
• Altman BJ, Jacobs SR, Mason EF, Michalek RD, MacIntyre AN, Coloff JL, Ilkayeva O, Jia W, He YW, Rathmell JC. Autophagy is essential to suppress cell stress and to allow BCR-Abl-mediated leukemogenesis. Oncogene 2011; 30:1855-67; PMID:21151168; http://dx.doi.org/10.1038/onc.2010.561
   PubMed Web of Science ®Google Scholar
• Ekiz HA, Can G, Baran Y. Role of autophagy in the progression and suppression of leukemias. Crit Rev Oncol Hematol 2012; 81:275-85; PMID:21612942; http://dx.doi.org/10.1016/j.critrevonc.2011.03.009
   PubMed Web of Science ®Google Scholar
• Carew JS, Nawrocki ST, Kahue CN, Zhang H, Yang C, Chung L, Houghton JA, Huang P, Giles FJ, Cleveland JL. Targeting autophagy augments the anticancer activity of the histone deacetylase inhibitor SAHA to overcome Bcr-Abl-mediated drug resistance. Blood 2007; 110:313-22; PMID:17363733; http://dx.doi.org/10.1182/blood-2006-10-050260
   PubMed Web of Science ®Google Scholar
• Mishima Y, Terui Y, Mishima Y, Taniyama A, Kuniyoshi R, Takizawa T, Kimura S, Ozawa K, Hatake K. Autophagy and autophagic cell death are next targets for elimination of the resistance to tyrosine kinase inhibitors. Cancer Sci 2008; 99:2200-8; PMID:18823378; http://dx.doi.org/10.1111/j.1349-7006.2008.00932.x
   PubMed Web of Science ®Google Scholar
• Kamitsuji Y, Kuroda J, Kimura S, Toyokuni S, Watanabe K, Ashihara E, Tanaka H, Yui Y, Watanabe M, Matsubara H, et al. The Bcr-Abl kinase inhibitor INNO-406 induces autophagy and different modes of cell death execution in Bcr-Abl-positive leukemias. Cell Death Differ 2008; 15:1712-22; PMID:18617896; http://dx.doi.org/10.1038/cdd.2008.107
   PubMed Web of Science ®Google Scholar
• Bellodi C, Lidonnici MR, Hamilton A, Helgason GV, Soliera AR, Ronchetti M, Galavotti S, Young KW, Selmi T, Yacobi R, et al. Targeting autophagy potentiates tyrosine kinase inhibitor-induced cell death in Philadelphia chromosome-positive cells, including primary CML stem cells. J Clin Invest 2009; 119:1109-23; PMID:19363292; http://dx.doi.org/10.1172/JCI35660
   PubMed Web of Science ®Google Scholar
• Crowley LC, Elzinga BM, O'Sullivan GC, McKenna SL. Autophagy induction by Bcr-Abl-expressing cells facilitates their recovery from a targeted or nontargeted treatment. Am J Hematol 2011; 86:38-47; PMID:21132731; http://dx.doi.org/10.1002/ajh.21914
   PubMed Web of Science ®Google Scholar
• Zhu S, Cao L, Yu Y, Yang L, Yang M, Liu K, Huang J, Kang R, Livesey KM, Tang D. Inhibiting autophagy potentiates the anticancer activity of IFN1@/IFNα in chronic myeloid leukemia cells. Autophagy 2013; 9:317-27; PMID:23242206; http://dx.doi.org/10.4161/auto.22923
   PubMed Web of Science ®Google Scholar
• Abe MK, Saelzler MP, Espinosa R, Kahle KT, Hershenson MB, Le Beau MM, Rosner MR. ERK8, a new member of the mitogen-activated protein kinase family. J Biol Chem 2002; 277:16733-43; PMID:11875070; http://dx.doi.org/10.1074/jbc.M112483200
   PubMed Web of Science ®Google Scholar
• Klevernic IV, Martin NM, Cohen P. Regulation of the activity and expression of ERK8 by DNA damage. FEBS Lett 2009; 583:680-4; PMID:19166846; http://dx.doi.org/10.1016/j.febslet.2009.01.011
   PubMed Web of Science ®Google Scholar
• Colecchia D, Strambi A, Sanzone S, Iavarone C, Rossi M, Dall'Armi C, Piccioni F, Verrotti di Pianella A, Chiariello M. MAPK15/ERK8 stimulates autophagy by interacting with LC3 and GABARAP proteins. Autophagy 2012; 8:1724-40; PMID:22948227; http://dx.doi.org/10.4161/auto.21857
   PubMed Web of Science ®Google Scholar
• Iavarone C, Acunzo M, Carlomagno F, Catania A, Melillo RM, Carlomagno SM, Santoro M, Chiariello M. Activation of the Erk8 mitogen-activated protein (MAP) kinase by RET/PTC3, a constitutively active form of the RET proto-oncogene. J Biol Chem 2006; 281:10567-76; PMID:16484222; http://dx.doi.org/10.1074/jbc.M513397200
   PubMed Web of Science ®Google Scholar
• Xu YM, Zhu F, Cho YY, Carper A, Peng C, Zheng D, Yao K, Lau AT, Zykova TA, Kim HG, et al. Extracellular signal-regulated kinase 8-mediated c-Jun phosphorylation increases tumorigenesis of human colon cancer. Cancer Res 2010; 70:3218-27; PMID:20395206; http://dx.doi.org/10.1158/0008-5472.CAN-09-4306
   PubMed Web of Science ®Google Scholar
• Abe MK, Kuo WL, Hershenson MB, Rosner MR. Extracellular signal-regulated kinase 7 (ERK7), a novel ERK with a C-terminal domain that regulates its activity, its cellular localization, and cell growth. Mol Cell Biol 1999; 19:1301-12; PMID:9891064
   PubMed Web of Science ®Google Scholar
• Mayer BJ, Baltimore D. Mutagenic analysis of the roles of SH2 and SH3 domains in regulation of the Abl tyrosine kinase. Mol Cell Biol 1994; 14:2883-94; PMID:8164650
   PubMed Web of Science ®Google Scholar
• Wetzler M, Talpaz M, Van Etten RA, Hirsh-Ginsberg C, Beran M, Kurzrock R. Subcellular localization of Bcr, Abl, and Bcr-Abl proteins in normal and leukemic cells and correlation of expression with myeloid differentiation. J Clin Invest 1993; 92:1925-39; PMID:8408645; http://dx.doi.org/; http://dx.doi.org/10.1172/JCI116786
   PubMed Web of Science ®Google Scholar
• Dixon AS, Constance JE, Tanaka T, Rabbitts TH, Lim CS. Changing the subcellular location of the oncoprotein Bcr-Abl using rationally designed capture motifs. Pharm Res 2012; 29:1098-109; PMID:22183511; http://dx.doi.org/10.1007/s11095-011-0654-8
   PubMed Web of Science ®Google Scholar
• Hantschel O, Wiesner S, Güttler T, Mackereth CD, Rix LL, Mikes Z, Dehne J, Görlich D, Sattler M, Superti-Furga G. Structural basis for the cytoskeletal association of Bcr-Abl/c-Abl. Mol Cell 2005; 19:461-73; PMID:16109371; http://dx.doi.org/10.1016/j.molcel.2005.06.030
   PubMed Web of Science ®Google Scholar
• Vigneri P, Wang JY. Induction of apoptosis in chronic myelogenous leukemia cells through nuclear entrapment of BCR-ABL tyrosine kinase. Nat Med 2001; 7:228-34; PMID:11175855; http://dx.doi.org/10.1038/84683
   PubMed Web of Science ®Google Scholar
• Preyer M, Vigneri P, Wang JY. Interplay between kinase domain autophosphorylation and F-actin binding domain in regulating imatinib sensitivity and nuclear import of BCR-ABL. PLoS One 2011; 6:e17020; PMID:21347248
   PubMed Web of Science ®Google Scholar
• Rossi M, Colecchia D, Iavarone C, Strambi A, Piccioni F, Verrotti di Pianella A, Chiariello M. Extracellular signal-regulated kinase 8 (ERK8) controls estrogen-related receptor α (ERRα) cellular localization and inhibits its transcriptional activity. J Biol Chem 2011; 286:8507-22; PMID:21190936; http://dx.doi.org/10.1074/jbc.M110.179523
   PubMed Web of Science ®Google Scholar
• Drullion C, Trégoat C, Lagarde V, Tan S, Gioia R, Priault M, Djavaheri-Mergny M, Brisson A, Auberger P, Mahon FX, et al. Apoptosis and autophagy have opposite roles on imatinib-induced K562 leukemia cell senescence. Cell Death Dis 2012; 3:e373; PMID:22898871; http://dx.doi.org/10.1038/cddis.2012.111
   PubMed Web of Science ®Google Scholar
• Liu F, Lee JY, Wei H, Tanabe O, Engel JD, Morrison SJ, Guan JL. FIP200 is required for the cell-autonomous maintenance of fetal hematopoietic stem cells. Blood 2010; 116:4806-14; PMID:20716775; http://dx.doi.org/10.1182/blood-2010-06-288589
   PubMed Web of Science ®Google Scholar
• Mortensen M, Watson AS, Simon AK. Lack of autophagy in the hematopoietic system leads to loss of hematopoietic stem cell function and dysregulated myeloid proliferation. Autophagy 2011; 7:1069-70; PMID:21552009; http://dx.doi.org/10.4161/auto.7.9.15886
   PubMed Web of Science ®Google Scholar
• Klionsky DJ, Abdalla FC, Abeliovich H, Abraham RT, Acevedo-Arozena A, Adeli K, Agholme L, Agnello M, Agostinis P, Aguirre-Ghiso JA, et al. Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy 2012; 8:445-544; PMID:22966490; http://dx.doi.org/10.4161/auto.19496
   PubMed Web of Science ®Google Scholar
• Henrich M, Smith A, Kitt D, Errington M, Nguyen B, Traish M, Lannigan A. Extracellular Signal-Regulated Kinase 7, a Regulator of Hormone-Dependent Estrogen Receptor Destruction. Mol Cell Biol 2003; 23:5979-88; PMID:12917323; http://dx.doi.org/10.1128/MCB.23.17.5979-5988.2003
   PubMed Web of Science ®Google Scholar
• Groehler AL, Lannigan DA. A chromatin-bound kinase, ERK8, protects genomic integrity by inhibiting HDM2-mediated degradation of the DNA clamp PCNA. J Cell Biol 2010; 190:575-86; PMID:20733054; http://dx.doi.org/10.1083/jcb.201002124
   PubMed Web of Science ®Google Scholar
• Cerone MA, Burgess DJ, Naceur-Lombardelli C, Lord CJ, Ashworth A. High-throughput RNAi screening reveals novel regulators of telomerase. Cancer Res 2011; 71:3328-40; PMID:21531765; http://dx.doi.org/10.1158/0008-5472.CAN-10-2734
   PubMed Web of Science ®Google Scholar
• Lugo TG, Pendergast AM, Muller AJ, Witte ON. Tyrosine kinase activity and transformation potency of bcr-abl oncogene products. Science 1990; 247:1079-82; PMID:2408149; http://dx.doi.org/10.1126/science.2408149
   PubMed Web of Science ®Google Scholar
• Wang LH. Molecular signaling regulating anchorage-independent growth of cancer cells. Mt Sinai J Med 2004; 71:361-7; PMID:15592654
   PubMed Web of Science ®Google Scholar
• Hasygar K, Hietakangas V. p53- and ERK7-Dependent Ribosome Surveillance Response Regulates Drosophila Insulin-Like Peptide Secretion. PLoS Genet 2014; 10:e1004764; PMID:25393288; http://dx.doi.org/10.1371/journal.pgen.1004764
   PubMed Web of Science ®Google Scholar
• Miyatake K, Kusakabe M, Takahashi C, Nishida E. ERK7 regulates ciliogenesis by phosphorylating the actin regulator CapZIP in cooperation with Dishevelled. Nat Commun 2015; 6:6666; PMID:25823377; http://dx.doi.org/10.1038/ncomms7666
   PubMed Web of Science ®Google Scholar
• Zacharogianni M, Kondylis V, Tang Y, Farhan H, Xanthakis D, Fuchs F, Boutros M, Rabouille C. ERK7 is a negative regulator of protein secretion in response to amino-acid starvation by modulating Sec16 membrane association. EMBO J 2011; 30:3684-700; PMID:21847093; http://dx.doi.org/10.1038/emboj.2011.253
   PubMed Web of Science ®Google Scholar
• Goussetis DJ, Gounaris E, Wu EJ, Vakana E, Sharma B, Bogyo M, Altman JK, Platanias LC. Autophagic degradation of the BCR-ABL oncoprotein and generation of antileukemic responses by arsenic trioxide. Blood 2012; 120:3555-62; PMID:22898604; http://dx.doi.org/10.1182/blood-2012-01-402578
   PubMed Web of Science ®Google Scholar
• Elzinga BM, Nyhan MJ, Crowley LC, O'Donovan TR, Cahill MR, McKenna SL. Induction of autophagy by Imatinib sequesters Bcr-Abl in autophagosomes and down-regulates Bcr-Abl protein. Am J Hematol 2013; 88:455-62; PMID:23440701; http://dx.doi.org/10.1002/ajh.23428
   PubMed Web of Science ®Google Scholar
• Strambi A, Mori M, Rossi M, Colecchia D, Manetti F, Carlomagno F, Botta M, Chiariello M. Structure prediction and validation of the ERK8 kinase domain. PLoS One 2013; 8:e52011; PMID:23326322; http://dx.doi.org/10.1371/journal.pone.0052011
   PubMed Web of Science ®Google Scholar
• Aceves-Luquero CI, Agarwal A, Callejas-Valera JL, Arias-González L, Esparís-Ogando A, del Peso Ovalle L, Bellón-Echeverria I, de la Cruz-Morcillo MA, Galán Moya EM, Moreno Gimeno I, et al. ERK2, but not ERK1, mediates acquired and "de novo" resistance to imatinib mesylate: implication for CML therapy. PLoS One 2009; 4:e6124; PMID:19568437; http://dx.doi.org/10.1371/journal.pone.0006124
   PubMed Web of Science ®Google Scholar
• Kweon SM, Cho YJ, Minoo P, Groffen J, Heisterkamp N. Activity of the Bcr GTPase-activating domain is regulated through direct protein/protein interaction with the Rho guanine nucleotide dissociation inhibitor. J Biol Chem 2008; 283:3023-30; PMID:18070886; http://dx.doi.org/10.1074/jbc.M705513200
   PubMed Web of Science ®Google Scholar
• Nicoletti I, Migliorati G, Pagliacci MC, Grignani F, Riccardi C. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods 1991; 139:271-9; PMID:1710634; http://dx.doi.org/10.1016/0022-1759(91)90198-O
   PubMed Web of Science ®Google Scholar